[Press release] Bioplus established joint venture in Hainan special district…securing bridgehead in chinese market
provide filler production and medical health services…done with business registration.
[inews24 Park Myung-jin Reporter]
Bioplus Co., Ltd., a filler company, announced on the 25th that it has established a joint corporation in Haenam, China, for the purpose of producing filler as well as medical and health services, and has also completed business registration.
Bioplus established ‘Bioplus Hainan Co.’ in the pilot area of Haenam, China, where the Chinese government announced its development plan as a free trade port, and completed registration in China.
Bioplus is a bio-strong company that has been recognized for its global technological competitiveness and specializes in hyaluronic acid filler, while its manufacturing technology is named as ‘MDM filler’ technology. “MDM filler” is a unique product name of Bioplus that applies three innovative high-end technologies among technologies that make filler using hyaluronic acid as raw material, and produces brands such as “Hyal Dew” and “Skin Plus Hyal.
Bioplus plans to produce filler directly in China and sell and export it to mainland China, Hong Kong and Southeast Asia. It will also have a “well-being-health” medical hospital with a more advanced concept than hospitals in the Boao area in Haenam Province.
To that end, Bioplus is currently building facilities that combine K-Bio industry with K-Health and an eco-friendly ecological park.
Along with anti-adhesive agent, Bioplus’ filler products have already passed the ‘MDSAP’ screening, a single European EC-held and medical device screening program. Through this process, it is exporting to South America, Australia, Europe, Southeast Asia and Russia.
Reporter Park Myung-jin email@example.com